All posts by: Michael Zand

About Michael Zand

Singapore’s IP Office to Grant Merck’s Patent Application for CRISPR Technology – Markets Insider

Continue reading

2017-12-19 NEWS

Singapore’s IP Office to Grant Merck’s Patent Application for CRISPR Technology
Markets Insider
This forthcoming, fundamental patent in Singapore, entitled “CRISPR-BASED GENOME MODIFICATION AND REGULATION,” covers chromosomal integration, or cutting of the chromosomal sequence of eukaryotic cells (such as mammalian and plant cells) and insertion

and more »

Continue reading

2017-12-19 NEWS

BioPharma-Reporter.com

Takeda’s off-the-shelf stem cell therapy closes in on EU approval
BioPharma-Reporter.com
The EMA has recommended approval of the first ever off-the-shelf stem cell therapy, Takeda and Tigenix’s Alofisel (darvadstrocel). The European Medicines Agency (EMA) adopted a positive opinion recommending marketing authorisation of the candidate
Is Buying All-time Stock Like TiGenix NV (TIG) a Winning Strategy?Frisco Fastball

all 5 news articles »

Continue reading

2017-12-19 NEWS

Stem cell expert named as Medical Research Council head
Times Higher Education (THE)
Professor Watt is a world-renowned expert on the skin’s stem cells. She is currently the director of the Centre for Stem Cells and Regenerative Medicine at Kings College London and leads a team of 80 researchers. Professor Watt said: “I am deeply

Continue reading

2017-12-19 NEWS

KAGS News

Immunotherapy closing in on a cure for cancer
KAGS News
It’s no secret, Kentucky leads the nation in lung cancer deaths as a tobacco-rich state with a high rate of radon and pollution. In the Bluegrass, more than 4,800 people are diagnosed with lung cancer every year and until recently, more than half would

and more »

Continue reading

2017-12-19 NEWS

Fed. Circ. Upholds Genzyme’s Win In Stem Cell Patent Case
Law360
Law360, New York (December 18, 2017, 7:04 PM EST) — The Federal Circuit on Monday affirmed a Delaware federal judge’s finding in a bench trial that a Genzyme Corp. patent on harvesting stem cells is valid, leaving in place a ruling that barred generic

and more »

Continue reading

2017-12-18 NEWS

Futurism

Mature Cells May Play an Important Role in the Onset of Cancer
Futurism
A new study has found that mature cells, as well as rapidly dividing stem cells, might play a role in the onset of cancer in the human body. A team of researchers from the Washington University School of Medicine in St. Louis observed mature cells
Mature Cell Discovery Could Cause a Rethink on the Origins of CancerGenetic Engineering & Biotechnology News
Study Prompts New Ideas on Cancers’ OriginsManaged Care magazine

all 5 news articles »